Clinical Trial Update: Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

View source ↗

Summary

This clinical trial registry entry describes a study to evaluate changes in quality of life for adults with moderate-to-severe plaque psoriasis treated with ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Plaque Psoriasis | Status: RECRUITING